<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Lymphoid enhancer-binding factor 1 (LEF1) is a neutrophilic granulopoiesis regulator whose absence is critical in <z:hpo ids='HP_0005549'>congenital neutropenia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We have shown LEF1 downregulation in the CD34(+) cells of the majority of <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) patients </plain></SENT>
<SENT sid="2" pm="."><plain>LEF1 was the most significant differentially expressed gene between early and advanced <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Marked LEF1 downregulation was found in 27/32 patients with advanced <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and in 6/35 patients with early <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, and was associated with <z:hpo ids='HP_0001875'>neutropenia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Downregulation of LEF1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> was reflected at the protein level </plain></SENT>
<SENT sid="5" pm="."><plain>Immunostaining for CD34/LEF1 may represent a marker of advanced <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>LEF1 may play a role in the defective maturation of myeloid progenitors in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>